EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy

Kengo Hamamura iD, Yuya Yoshida iD, Kosuke Oyama iD, Junhao Li, Shimpei Kawano, Kimiko Inoue, Keiko Toyooka, Misaki Yamadera iD, Naoya Matsunaga, Tsuyoshi Matsumura iD, Kosuke Aritake

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25031846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kengo Hamamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Daiichi University of Pharmacy, Fukuoka 815-8511, Japan. Hauptthemen laut MEDLINE: Cardiomyopathies, Intramolecular Oxidoreductases, Lipocalins, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research C from Japan for the Promotion of Science, Japan Agency for Medical Research and Development, Grant-in-Aid for Scientific Research C.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The leading cause of death for patients with Duchenne muscular dystrophy (DMD), a progressive muscle disease, is heart failure. Prostaglandin (PG) D2, a physiologically active fatty acid, is synthesized from the precursor PGH2 by hematopoietic prostaglandin D synthase (HPGDS). Using a DMD animal model (mdx mice), we previously found that HPGDS expression is increased not only in injured muscle but also in the heart. Moreover, HPGDS inhibitors can slow the progression of muscle injury and cardiomyopathy. However, the location of HPGDS in the heart is still unknown. Thus, this study investigated HPGDS expression in autopsy myocardial samples from DMD patients. We confirmed the presence of fibrosis, a characteristic phenotype of DMD, in the autopsy myocardial sections. Additionally, HPGDS was expressed in mast cells, pericytes, and myeloid cells of the myocardial specimens but not in the myocardium. Compared with the non-DMD group, the DMD group showed increased HPGDS expression in mast cells and pericytes. Our findings confirm the possibility of using HPGDS inhibitor therapy to suppress PGD2 production to treat skeletal muscle disorders and cardiomyopathy. It thus provides significant insights for developing therapeutic drugs for DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesIntramolecular OxidoreductasesLipocalinsMuscular Dystrophy, DuchenneAnimalsHumansMiceDisease Models, AnimalMast CellsMice, Inbred mdxMuscle, SkeletalMyocardiumPericytes

Stichwörter der Autor:innen

Duchenne muscular dystrophyhematopoietic prostaglandin D synthasemast cellmyeloid cellpericyteprostaglandin D2

Substanzen

Intramolecular OxidoreductasesLipocalinsprostaglandin R2 D-isomeraseHPGDS protein, human

Autor:innen und Institutionen

  • Laboratory of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Daiichi University of Pharmacy, Fukuoka 815-8511, Japan.
  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Neurology and Rehabilitation Medicine, National Hospital Organization Osaka Toneyama Medical Center, Toneyama 5-1-1, Toyonaka 560-8552, Japan.
  • Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center, Toneyama 5-1-1, Toyonaka 560-8552, Japan.
  • Department of Clinical Research, National Hospital Organization Osaka Toneyama Medical Center, Toneyama 5-1-1, Toyonaka 560-8552, Japan.

ORCID-Profile: Kengo Hamamura, Yuya Yoshida, Kosuke Oyama, Misaki Yamadera, Tsuyoshi Matsumura

Förderung

  • Grant-in-Aid for Scientific Research C from Japan for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Grant-in-Aid for Scientific Research C
  • Promotion of Science and AMED

Zitieren

APA

Hamamura, K., Yoshida, Y., Oyama, K., Li, J., Kawano, S., Inoue, K., Toyooka, K., Yamadera, M., Matsunaga, N., Matsumura, T., & Aritake, K. (2024). Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031846

Vancouver

Hamamura K, Yoshida Y, Oyama K, Li J, Kawano S, Inoue K, et al. Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031846

BibTeX
@article{Hamamura2024,
  author = {Hamamura, Kengo and Yoshida, Yuya and Oyama, Kosuke and Li, Junhao and Kawano, Shimpei and Inoue, Kimiko and Toyooka, Keiko and Yamadera, Misaki and Matsunaga, Naoya and Matsumura, Tsuyoshi and Aritake, Kosuke},
  title = {Hematopoietic Prostaglandin D Synthase Is Increased in Mast Cells and Pericytes in Autopsy Myocardial Specimens from Patients with Duchenne Muscular Dystrophy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25031846}
}
Kostenlos starten →